IL‐25 enhances TH17 cell–mediated contact dermatitis by promoting IL‐1&bgr; production by dermal dendritic cells

[1]  S. Ziegler,et al.  The atopic march: current insights into skin barrier dysfunction and epithelial cell‐derived cytokines , 2017, Immunological reviews.

[2]  W. Boehncke,et al.  Keratinocyte-Derived IL-17E Contributes to Inflammation in Psoriasis. , 2016, The Journal of investigative dermatology.

[3]  D. Artis,et al.  Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis , 2016, Nature Immunology.

[4]  Ying Sun,et al.  Interleukin (IL)‐25: Pleiotropic roles in asthma , 2016, Respirology.

[5]  G. Ogg,et al.  A role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis , 2013, The Journal of experimental medicine.

[6]  N. Balato,et al.  The balance between pro‐ and anti‐inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL‐1 family members , 2013, Experimental dermatology.

[7]  P. Srimanote,et al.  Interleukin-25 (IL-25) Promotes Efficient Protective Immunity against Trichinella spiralis Infection by Enhancing the Antigen-Specific IL-9 Response , 2013, Infection and Immunity.

[8]  K. Ohta,et al.  Epithelial Cell-Derived IL-25, but Not Th17 Cell-Derived IL-17 or IL-17F, Is Crucial for Murine Asthma , 2012, The Journal of Immunology.

[9]  Yong‐jun Liu,et al.  Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. , 2011, The Journal of allergy and clinical immunology.

[10]  A. Waisman,et al.  Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. , 2011, Immunity.

[11]  C. Vestergaard,et al.  IL-25 in atopic dermatitis: a possible link between inflammation and skin barrier dysfunction? , 2011, The Journal of investigative dermatology.

[12]  C. Dong,et al.  IL-17 family member cytokines: regulation and function in innate immunity. , 2010, Cytokine & growth factor reviews.

[13]  T. Abe,et al.  IL-33 is a crucial amplifier of innate rather than acquired immunity , 2010, Proceedings of the National Academy of Sciences.

[14]  H. Kiyonari,et al.  Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline‐competent embryonic stem cells of C57BL/6N mouse strain with high efficiency and stability , 2010, Genesis.

[15]  W. Paul,et al.  How are TH2-type immune responses initiated and amplified? , 2010, Nature Reviews Immunology.

[16]  S. Ziegler,et al.  Dibutyl Phthalate-Induced Thymic Stromal Lymphopoietin Is Required for Th2 Contact Hypersensitivity Responses , 2010, The Journal of Immunology.

[17]  S. Nakae,et al.  Development of IL-17-mediated delayed-type hypersensitivity is not affected by down-regulation of IL-25 expression. , 2010, Allergology international : official journal of the Japanese Society of Allergology.

[18]  S. Nakae,et al.  IL-1 and Allergy. , 2010, Allergology international : official journal of the Japanese Society of Allergology.

[19]  R. Flavell,et al.  Caspase-1, Caspase-8, and Calpain Are Dispensable for IL-33 Release by Macrophages1 , 2009, The Journal of Immunology.

[20]  D. Artis,et al.  Welcome to the neighborhood: epithelial cell‐derived cytokines license innate and adaptive immune responses at mucosal sites , 2008, Immunological reviews.

[21]  S. Nakae,et al.  The roles of IL‐17A in inflammatory immune responses and host defense against pathogens , 2008, Immunological reviews.

[22]  W. Paul,et al.  CD4 T cells: fates, functions, and faults. , 2008, Blood.

[23]  R. Kastelein,et al.  Commensal-dependent expression of IL-25 regulates the IL-23–IL-17 axis in the intestine , 2008, The Journal of experimental medicine.

[24]  S. Nakae,et al.  Th17 and allergy. , 2008, Allergology international : official journal of the Japanese Society of Allergology.

[25]  K. Chung,et al.  Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.

[26]  Yong‐jun Liu,et al.  IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC–activated Th2 memory cells , 2007, The Journal of experimental medicine.

[27]  Yong‐jun Liu,et al.  Interleukin 25 promotes the initiation of proallergic type 2 responses , 2007, The Journal of experimental medicine.

[28]  D. Jarrossay,et al.  Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells , 2007, Nature Immunology.

[29]  S. Galli,et al.  Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL‐17 , 2007, Journal of leukocyte biology.

[30]  T. Mcclanahan,et al.  IL-25 regulates Th17 function in autoimmune inflammation , 2007, The Journal of experimental medicine.

[31]  T. Mcclanahan,et al.  Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract , 2006, The Journal of experimental medicine.

[32]  Niamh E Mangan,et al.  Identification of an interleukin (IL)-25–dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion , 2006, The Journal of experimental medicine.

[33]  M. Tsai,et al.  Mast Cell-Associated TNF Promotes Dendritic Cell Migration1 , 2006, The Journal of Immunology.

[34]  Yong‐jun Liu,et al.  Thymic stromal lymphopoietin: master switch for allergic inflammation , 2006, The Journal of experimental medicine.

[35]  Kotaro Suzuki,et al.  Mast cells produce interleukin-25 upon FcεRI-mediated activation , 2003 .

[36]  D. Danilenko,et al.  Transgenic overexpression of human IL-17E results in eosinophilia, B-lymphocyte hyperplasia, and altered antibody production. , 2002, Blood.

[37]  R. Coffman,et al.  New IL-17 Family Members Promote Th1 or Th2 Responses in the Lung: In Vivo Function of the Novel Cytokine IL-251 , 2002, The Journal of Immunology.

[38]  S. Nakae,et al.  IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity , 2001 .

[39]  A. Gurney,et al.  Forced Expression of Murine IL-17E Induces Growth Retardation, Jaundice, a Th2-Biased Response, and Multiorgan Inflammation in Mice , 2001, The Journal of Immunology.

[40]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[41]  A. Shaw,et al.  Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice. , 1995, Immunity.